CHA Biotech Co. Ltd Cash Flow Quality Index
CHA Biotech Co. Ltd cash flow quality index. CHA Biotech Co. Ltd (085660) has a Cash Flow Quality Index of -0.01x as of June 2026. Operating cash flow of ₩-208.26 Million is below net income of ₩29.26 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore how well can CHA Biotech Co. Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of CHA Biotech Co. Ltd (2009–2019)
Cash flow quality index of CHA Biotech Co. Ltd from 2009 to 2019. Historical Cash Flow Quality Index for CHA Biotech Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. See CHA Biotech Co. Ltd balance sheet independence to measure how much of total assets are equity-financed.
CHA Biotech Co. Ltd Cash Flow Quality Index by Year (2009–2019)
CHA Biotech Co. Ltd cash flow quality index by year from 2009 to 2019. Year-by-year earnings quality comparison for CHA Biotech Co. Ltd. For the full cash flow conversion analysis, see 085660 operating cash flow.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 0.54x | ₩25.24 Billion | ₩46.37 Billion | ▼ -82.4% |
| 2018 | 3.09x | ₩75.38 Billion | ₩24.39 Billion | ▲ +649.9% |
| 2016 | 0.41x | ₩11.29 Billion | ₩27.40 Billion | ▲ +145.8% |
| 2014 | -0.90x | ₩-2.57 Billion | ₩2.85 Billion | ▼ -134.5% |
| 2013 | 2.61x | ₩66.35 Billion | ₩25.45 Billion | ▲ +39.3% |
| 2012 | 1.87x | ₩45.77 Billion | ₩24.45 Billion | ▼ -78.3% |
| 2011 | 8.64x | ₩34.69 Billion | ₩4.02 Billion | ▲ +4.9% |
| 2010 | 8.24x | ₩42.07 Billion | ₩5.11 Billion | ▲ +86.6% |
| 2009 | 4.41x | ₩24.02 Billion | ₩5.44 Billion | — |